Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

NCT04394351 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis (EoE)

Interventions

DRUG: Dupilumab
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]